Literature DB >> 28204465

Global seroprevalence of rubella among pregnant and childbearing age women: a meta-analysis.

E Pandolfi1, F Gesualdo1, C Rizzo2, A Bella2, E Agricola1, P Mastroiacovo3, A E Tozzi1.   

Abstract

Background: We conducted a meta-analysis of articles published between January 2000 and July 2016 with the aim of defining the proportion of rubella seronegative women of childbearing age (WCBA), providing the best information available on the seroprevalence of rubella in this population. We selected articles published in the time period between 2000 and 2016. The pooled prevalence of rubella seronegative women was calculated by a fixed effect model and a random effect model, according to the heterogeneity among studies. Studies were sub-grouped by population type (pregnant women and WCBA with no mention of ongoing pregnancy) and by geographic area [World Health Organization (WHO) region]. Sensitivity analysis was performed to assess the stability of results. We found important differences in rubella seronegativity prevalence estimates by WHO Region. About 88% of the studies conducted on pregnant women reported a seronegativity rate >5%. The pooled rubella seronegativity prevalence was 9.3%. When considering population groups, we obtained a seronegativity pooled estimate of 9.4% for pregnant women and of 9.5% for WCBA with no mention of ongoing pregnancy. This meta-analysis shows that the proportion of WCBA who are susceptible to rubella is still high. The figures are worrisome, taking into account that the WHO set at 5% the rubella susceptibility threshold for WCBA.
© The Author 2017. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28204465     DOI: 10.1093/eurpub/ckw259

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  7 in total

1.  Sero-prevalence of rubella among pregnant women in Sub-Saharan Africa: a meta-analysis.

Authors:  Zemenu Yohannes Kassa; Siraj Hussen; Solomon Asnake
Journal:  Hum Vaccin Immunother       Date:  2020-03-20       Impact factor: 3.452

2.  Seroprevalence of Rubella Virus-specific Antibodies in Women and the Diagnostic Efficacy of Enzyme-linked Immunoassay and Rapid Immunochromatographic Tests.

Authors:  Praveen R Shahapur; Venkataramana Kandi
Journal:  Cureus       Date:  2020-03-12

3.  Seroprevalence data at a private teaching hospital in Kenya: An examination of Toxoplasma gondii, cytomegalovirus, rubella, hepatitis A, and Entamoeba histolytica.

Authors:  Audrey I Nisbet; Geoffrey Omuse; Gunturu Revathi; Rodney D Adam
Journal:  PLoS One       Date:  2018-10-16       Impact factor: 3.240

4.  Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization.

Authors:  Florin Gorun; Daniel Malita; Ioana Ciohat; Tatjana Vilibic-Cavlek; Horea Feier; Irena Tabain; Marius Craina; Octavian Cretu; Dan Navolan
Journal:  Vaccines (Basel)       Date:  2021-01-29

5.  Susceptibility to Rubella Infection and Incidence of Congenital Rubella Infection: 6 Years Retrospective Study.

Authors:  Reem A Al Dossary; Sarah Althuwaiqeb; Khaled R Alkharsah; Nahid H O Wanni; Basavaraja C Hunasemaranda; Obeid E Obeid; Zaheenul Islam Siddiqui; Ayman A El-Badry; Nourah Hasan Al Qahtani
Journal:  Int J Gen Med       Date:  2022-04-02

6.  Reduction in Rubella Virus Active Cases among Children and Adolescents after Rubella Vaccine Implementation in Tanzania: A Call for Sustained High Vaccination Coverage.

Authors:  Fausta Michael; Mariam M Mirambo; Dafrossa Lyimo; Furaha Kyesi; Delfina R Msanga; Georgina Joachim; Honest Nyaki; Richard Magodi; Delphius Mujuni; Florian Tinuga; Ngwegwe Bulula; Bonaventura Nestory; Dhamira Mongi; Ahmed Makuwani; Betina Katembo; William Mwengee; Alex Mphuru; Nassor Mohamed; David Kayabu; Helmut Nyawale; Eveline T Konje; Stephen E Mshana
Journal:  Vaccines (Basel)       Date:  2022-07-27

7.  Recent trends in seroprevalence of rubella in Korean women of childbearing age: a cross-sectional study.

Authors:  Rihwa Choi; Yejin Oh; Youngju Oh; Sung Ho Kim; Sang Gon Lee; Eun Hee Lee
Journal:  BMJ Open       Date:  2020-01-02       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.